'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Vivanza Biosciences Limited
VIVANZA (BSE 530057) · ISIN INE984E01035 · Pharmaceuticals · Est. 1982 · listed 1995 · website
Not on any surveillance list
Next: Board meeting: financial results on 3 November 2026.
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹4.4 cr | ₹7.5 cr | ₹18.23 cr |
| 30 Sep 2025 standalone | ₹4.5 cr | ₹7.28 cr | ₹45.13 cr |
| 31 Mar 2025 standalone | ₹4.02 cr | ₹6.09 cr | ₹13.91 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 20.02% | — | 0.00% | 79.98% |
Latest filings
- Voting Result for the 44th Annual General Meeting of the Company 12 September 2026 · BSE
- Revised Outcome of the 44th Annual General Meeting of the Vivanza Biosciences Limited 12 September 2026 · BSE
- Outcome of the 44th Annual General Meeting of the Members of the Vivanza Biosciences Limited. 11 September 2026 · BSE
- Annual Report FY2025-26 (New) 19 August 2026 · BSE
- Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26 19 August 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.